$ALXN Headlines Are consumers getting gouged on health

New Post Public Reply Private Reply Replies (0) Message Board

Dec 19, 2014 at 11:55 AM

$ALXN Headlines

Are consumers getting gouged on health care? 9:36 a.m. Nov. 22, 2014 - Russ Britt
Alexion Pharmaceuticals shares advance 5.3% 8:32 a.m. Oct. 23, 2014 - Sue Chang
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 3:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 10:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 2:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 3:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 8:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 2:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 5:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 3:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 3:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 4:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 3:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 1:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 11:48 a.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 3:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 3:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 3:16 p.m. March 21, 2014 - Sue Chang

Alexion's Rare Disease Model Analyzed 3:23 p.m. Dec. 18, 2014 - Seeking Alpha
Insider Trading Alert - DXCM, ALXN And FRGI Traded By Insiders 1:45 p.m. Dec. 17, 2014 - TheStreet.com
Biotech Stock Roundup: Sophiris & Cyclacel Plunge on Data, ChemoCentryx Gains on Positive Results - Analyst Blog 10:26 a.m. Dec. 17, 2014 - Zacks.com
Alexion Announces New Share Repurchase Program of $500M - Analyst Blog 6:55 p.m. Dec. 16, 2014 - Zacks.com
Alexion's Soliris Receives Orphan Drug Status in Japan - Analyst Blog 6:15 p.m. Dec. 15, 2014 - Zacks.com
United Therapeutics: Will It Pass Peers In 2015? 5:11 p.m. Dec. 12, 2014 - Investors Business Daily
IBD 50: Growth Stocks Fight The Fight In Weak Tape 5:11 p.m. Dec. 12, 2014 - Investors Business Daily
The New #47 Most Shorted Nasdaq 100 Component: Alexion Pharmaceuticals 4:21 p.m. Dec. 11, 2014 - TheStreet.com
ChemoCentryx: Can It Break Into The Soliris Market? 3:08 p.m. Dec. 11, 2014 - Seeking Alpha
Are Investors Signaling Optimism in Biotechs Through Short Interest? 9:24 a.m. Dec. 10, 2014 - 247WallSt.com
Insider Trading Alert - PNW, BCEI And ALXN Traded By Insiders 12:28 p.m. Dec. 9, 2014 - TheStreet.com
Two Gauges That Point To Fund Buying In A Stock 5:18 p.m. Dec. 8, 2014 - Investors Business Daily
Weekly CFO Sells Highlight: Alexion Pharmaceuticals Inc, Equity Residential, Tableau Software Inc. 9:41 a.m. Dec. 8, 2014 - GuruFocus.com
Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY 9:37 a.m. Dec. 8, 2014 - GuruFocus.com
Inside The IBD 50: Challenging Time For Growth Stocks 5:54 p.m. Dec. 5, 2014 - Investors Business Daily
3 Growth Stocks In Buy Range After Recent Breakouts 5:41 p.m. Dec. 3, 2014 - Investors Business Daily
Biotech Stock Roundup: Avanir to be Acquired by Japanese Firm, Biogen Scores in Alzheimer's Study - Analyst Blog 10:51 a.m. Dec. 3, 2014 - Zacks.com
Stock Market News for December 03, 2014 - Market News 10:10 a.m. Dec. 3, 2014 - Zacks.com
Today Alexion Pharmaceuticals (ALXN) Hits New Lifetime High 9:46 a.m. Dec. 3, 2014 - TheStreet.com
Meet 5 Big Caps Whose Earnings Are Expected To Surge 7:02 a.m. Dec. 3, 2014 - Investors Business Daily

Alexion Announces $500 Million Share Repurchase Program 6:30 a.m. Dec. 15, 2014 - BusinessWire - BZX
X-Chem and Alexion Collaborate to Discover Novel Therapeutic Candidates to Treat Patients with Severe and Ultra-Rare Disorders 8:57 a.m. Dec. 11, 2014 - BusinessWire - BZX
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Myasthenia Gravis 4:15 p.m. Dec. 10, 2014 - BusinessWire - BZX
New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge of aHUS and PNH and Underscore the Effectiveness of Soliris® (eculizumab) Treatment 9:00 p.m. Dec. 8, 2014 - BusinessWire - BZX
NICE Issues Final Positive Recommendation for National Commissioning of Soliris® (eculizumab) for All Patients with aHUS in England 4:46 a.m. Nov. 27, 2014 - BusinessWire - BZX
Soliris® (eculizumab) Granted Orphan Drug Designation in Japan for the Treatment of Patients with Neuromyelitis Optica 6:30 a.m. Nov. 25, 2014 - BusinessWire - BZX
Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment 10:00 a.m. Nov. 15, 2014 - BusinessWire - BZX
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015 6:30 a.m. Nov. 10, 2014 - BusinessWire - BZX
Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting 4:16 p.m. Nov. 6, 2014 - BusinessWire - BZX
Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Alexion Launches Every Day with HPP™ Campaign in Support of Hypophosphatasia (HPP) Awareness Week 4:51 p.m. Oct. 27, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 9:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Researchers to Present Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at ASN 2014 Annual Meeting 4:15 p.m. Oct. 23, 2014 - BusinessWire - BZX
Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Critical Alerts For Sears Holdings, JetBlue, Qlogic, Las Vegas Sands and Alexion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 15, 2014 - PR Newswire - PRF
Alexion Submits NDA in Japan for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Third Quarter 2014 Results on Thursday, October 23, 2014 10:00 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Board of Directors Appoints New Chairman and Creates the New Position of Lead Independent Director 6:30 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors 4:00 p.m. Oct. 7, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BLM's Wild Horse Strategy: Fertility Control's Time to Shine

Wild Horse Management Gets a Shot in the Arm Amigo, when the federal government throws $30 million dollars at a problem, you'd hope they're not just throwing us a bone. The Bureau of Land Management (BLM) now has this hefty sum courtesy of the U.S. Department of Agriculture, intended to expand wild horse fertility control across the sprawling landscapes they roam. This...

Multiply's AI Agent Tackles $126K Google Ads Waste

AI Steps In Where Marketers Hit a Wall Picture this: marketers drowning in search terms flying at them faster than they can blink. Multiply's new AI-powered Ad Spend Recovery Agent steps in, claiming to save an eye-watering $126,000 per year by cutting Google Ads waste. Talk about having a hawk-eyed auditor sifting through your accounts. Shaking Up Traditional Automation...

HiBy Unveils Cyberpunk 2077 Gaming Audio Line

HiBy Hits the Gaming Scene with Cyberpunk Flair It's a wild world when audio tech and gaming collide outside of the usual suspects. HiBy's latest move is a bold pivot into the gaming universe, launching an audacious collaboration with, of all things, the cybernetic chaos of Cyberpunk 2077. You can almost feel the underlying scrappiness of Night City embedded into a couple...

Klydoclock's Bold Move: Licensing International Boost

Revolutionizing Timekeeping with Art There’s this clock outfit, Klydoclock, that’s flipping the script on how we see time and art melding together. You see, they’ve taken those static old tick-tock reminders of the hour and juiced 'em up with animated art, turning your wall clock into something more akin to a mini art exhibit right in your living room. Ever heard of...

Alito's Recusal: Supreme Court Climate Case Shaker

Justice Alito Bows Out from A High-Stakes Climate Battle September 28, 2026, marked a notable turn in the legal landscape. Supreme Court Justice Samuel Alito chose to step away from a case that's got every investor, lawyer, and policy wonk on the edge of their seats—Suncor v. Boulder. This isn't about just any old courtroom squabble; it's a landmark climate case poised...

Schweid & Sons Reveals New Marinated Steak Tips Line

No More Prep Dilemmas: Schweid & Sons Unveils Steak Tips Packing a punch in the protein aisle, Schweid & Sons throws down the gauntlet with their latest culinary innovation — Marinated Steak Tips. These aren't just your run-of-the-mill cuts, folks. We're talking premium Tri-Tip, butcher-trimmed to perfection, and marinated in both Cajun and Teriyaki styles. It's all...

Claigan Webinar Tackles Prop 65 Warnings for 2028

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Beasley and Vegas Golden Knights Partner for Broadcast

Strategic Moves on the Airwaves The Vegas Golden Knights are skating into a new era of broadcasting. Teaming up with Beasley Media Group, they've inked a multiyear deal that makes the media outfit their official audio partner. Dropping the puck on this relationship means folks in Southern Nevada can catch the action on Beasley's English and Spanish stations. It's a hefty...

Gray's Rise in ENR Rankings Highlights Sector Dominance

Gray's Outstanding Reputation in the Construction Arena Nothing says “we're on top of our game” like snatching top slots in industry rankings, and that's precisely what Gray, the construction and engineering heavyweight, has managed to do. This firm recently secured impressive spots across ten different categories in the prestigious Engineering News-Record (ENR) Top...

Hyundai Teases 2027 TUCSON: Global Reveal Imminent

Hyundai Sets the Stage for the 2027 TUCSON Hyundai’s ready to roll out its shiny new set of wheels, the 2027 TUCSON, and boy, they sure know how to make an entrance. Mark your calendars for October 1—it's happening right in the Big Apple, none other than Long Island City. Expect the spotlight to hit at precisely 5:15 p.m. ET, and don't worry if you can't snag a...